Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
Santiago Romero-BrufauAyush ChopraAlexander J RyuEsma GelRamesh RaskarWalter K KremersKaren S AndersonJayakumar SubramanianBalaji KrishnamurthyAbhishek SinghKalyan S PasupathyYue DongJohn C O'HoroWalter R WilsonOscar J L MitchellThomas C KingsleyPublished in: BMJ (Clinical research ed.) (2021)
A delayed second dose vaccination strategy, at least for people aged under 65, could result in reduced cumulative mortality under certain conditions.